Search Results

Safety and Drug Utilization Profile of Varenicline as Used in General Practice in England: Interim Results from a Prescription-Event Monitoring Study

Authors: Kasliwal, Rachna; Wilton, Lynda V.; Shakir, Saad A.W.

Source: Drug Safety, Volume 32, Number 6, 21 May 2009 , pp. 499-507(9)

Publisher: Adis International

Hypoglycaemia with Oral Antidiabetic Drugs: Results from Prescription-Event Monitoring Cohorts of Rosiglitazone, Pioglitazone, Nateglinide and Repaglinide

Authors: Vlckova, Veronika; Cornelius, Victoria; Kasliwal, Rachna; Wilton, Lynda; Shakir, Saad A.W.

Source: Drug Safety, Volume 32, Number 5, 2009 , pp. 409-418(10)

Publisher: Adis International

Risk Management and Outcomes of Adverse Events to Pioglitazone in Primary Care in the UK: An Observational Study

Authors: Fogg, Carole; Kasliwal, Rachna; Shakir, Saad A.W.

Source: Drug Safety, Volume 32, Number 3, 2009 , pp. 229-237(9)

Publisher: Adis International

Examining the Tolerability of the Non-Sedating Antihistamine Desloratadine: A Prescription-Event Monitoring Study in England

Authors: Layton, Deborah; Wilton, Lynda; Shakir, Saad A.W.

Source: Drug Safety, Volume 32, Number 2, 2009 , pp. 169-179(11)

Publisher: Adis International

The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients

Authors: Hazell, Lorna; Cornelius, Victoria; Wilton, Lynda V.; Shakir, Saad A.W.

Source: BJU International, Volume 103, Number 4, February 2009 , pp. 506-514(9)

Publisher: Blackwell Publishing

Use and Risk Management of Carvedilol for the Treatment of Heart Failure in the Community in England: Results from a Modified Prescription-Event Monitoring Study

Authors: Aurich-Barrera, Beate; Wilton, Lynda V.; Shakir, Saad A.W.

Source: Drug Safety, Volume 32, Number 1, 2009 , pp. 43-54(12)

Publisher: Adis International

Monitoring the Safety of Pioglitazone: Results of a Prescription-Event Monitoring Study of 12 772 Patients in England

Authors: Kasliwal, Rachna; Wilton, Lynda V.; Shakir, Saad A.W.

Source: Drug Safety, Volume 31, Number 10, 2008 , pp. 839-850(12)

Publisher: Adis International

Safety Profile of Esomeprazole: Results of a Prescription-Event Monitoring Study of 11 595 Patients in England

Authors: Davies, Miranda; Wilton, Lynda V.; Shakir, Saad A.W.

Source: Drug Safety, Volume 31, Number 4, 2008 , pp. 313-323(11)

Publisher: Adis International

Tighter controls for ephedrine and pseudoephedrine contained in nasal decongestants will become law from 1 April 2008

Source: Reactions, Volume 1, Number 1184, 2008-01-12 , pp. 4-4(1)

Publisher: Adis International

Colchicine prescribing and safety monitoring on track in NZ

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 542, 2007-12-01 , pp. 7-7(1)

Publisher: Adis International

Colchicine prescribing and safety monitoring on track in NZ

Source: Inpharma, Volume 1, Number 1616, 2007-12-01 , pp. 3-3(1)

Publisher: Adis International

A Modified Prescription-Event Monitoring Study to Assess the Introduction of Seretide Evohaler™ in England: An Example of Studying Risk Monitoring in Pharmacovigilance

Authors: Perrio, Michael J.; Wilton, Lynda V.; Shakir, Saad A.W.

Source: Drug Safety, Volume 30, Number 8, 2007 , pp. 681-695(15)

Publisher: Adis International

Atypical antipsychotic utilisation among NZ kids

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 533, 2007-07-28 , pp. 6-6(1)

Publisher: Adis International

Safety and Usage of Atypical Antipsychotic Medicines in Children: A Nationwide Prospective Cohort Study

Authors: Harrison-Woolrych, Mira; Garcia-Quiroga, Juan; Ashton, Janelle; Herbison, Peter

Source: Drug Safety, Volume 30, Number 7, 2007 , pp. 569-579(11)

Publisher: Adis International

Thoughts on Signal Detection in Pharmacovigilance

Author: Shakir, Saad A.W.

Source: Drug Safety, Volume 30, Number 7, 2007 , pp. 603-606(4)

Publisher: Adis International

Prescription-Event Monitoring: Developments in Signal Detection

Author: Ferreira, Germano

Source: Drug Safety, Volume 30, Number 7, 2007 , pp. 639-641(3)

Publisher: Adis International

Safety of Zafirlukast: Results of a Postmarketing Surveillance Study on 7976 Patients in England

Authors: Twaites, Beverley R.; Wilton, Lynda V.; Shakir, Saad A.W.

Source: Drug Safety, Volume 30, Number 5, 2007 , pp. 419-429(11)

Publisher: Adis International

Multi-Constituent Cardiovascular Pills (MCCP) - Challenges and Promises of Population-Based Prophylactic Drug Therapy for Prevention of Heart Attack

Authors: Jamieson, Michael J.; Naghavi, Morteza

Source: Current Pharmaceutical Design, Volume 13, Number 10, April 2007 , pp. 1069-1076(8)

Publisher: Bentham Science Publishers

Postmarketing study supports rosuvastatin safety

Source: Reactions, Volume 1, Number 1140, 2007-02-24 , pp. 4-4(1)

Publisher: Adis International

Safety Profile of Rosuvastatin: Results of a Prescription-Event Monitoring Study of 11 680 Patients

Authors: Kasliwal, Rachna; Wilton, Lynda V.; Cornelius, Victoria; Aurich-Barrera, Beate; Shakir, Saad A.W.

Source: Drug Safety, Volume 30, Number 2, 2007 , pp. 157-170(14)

Publisher: Adis International